Technological Mapping of Point-of-Care Testing for the Diagnosis of Sickle Cell Anemia

Authors

DOI:

https://doi.org/10.9771/cp.v18i4.61431

Keywords:

Patents, Rapid Test, Sickle Cell Anemia.

Abstract

Sickle cell anemia is caused by a mutation that codes for the sixth amino acid of the beta chain of hemoglobin, resulting in a mutant variant of hemoglobin (HbS) that has different properties from wild-type hemoglobin (HbA). Rapid diagnostic tests for sickle cell disease that allow rapid detection at the point of care and are easy to use. This study presents a search of the Derwent World Patents Index database for patent documents related to rapid tests and sickle cell disease. The technology review shows that the United States and India are the top patent filing locations and that BioMedomics is the leader and pioneer in the production and global commercialization of a rapid test for sickle cell anemia. Thus, the technology landscape has been slow to evolve in the face of promising growth in the global market, with a focus on innovating rapid tests that are easy to analyse and cost effective.

Downloads

Download data is not yet available.

Author Biographies

Marcela Maiana Ramos da Silva, Federal University of Bahia

Master in Intellectual Property and Technology Transfer for Innovation from the Federal University of Bahia in 2024.

Bernardo Pereira Cabral, Fundação Oswaldo Cruz

Bernardo Pereira Cabral is an associate professor at the Faculty of Economics at the Federal University of Bahia (UFBA). He teaches undergraduate courses in Economic Sciences and is a permanent professor at the Postgraduate Program in Economics (PPGE) and the Postgraduate Program in Intellectual Property and Technology Transfer for Innovation (PROFNIT). He has a PhD in Economics of Industry and Technology from the Federal University of Rio de Janeiro (UFRJ) (2018) and a bachelor's degree (2010) and master's degree (2012) in Economics from the Federal University of Bahia. He also completed a postdoctoral degree at the Department of Scientific and Technological Policy at the State University of Campinas (DPCT / UNICAMP) (2024). He is a researcher and deputy leader of the Foresight Studies Center (NEF) and a collaborator at the Cellular Communication Laboratory (LCC), both at Fiocruz, where he carries out studies on mapping scientific and technological information and Technology Foresight. He is also a collaborator of the Research Program in the Management of Technological Learning and Innovation in Brazil at EBAPE / FGV and the Laboratory for Studies on the Organization of Research and Innovation at Unicamp (Lab-GEOPI).

References

ARISHI, Wjdan A.; ALHADRAMI, Hani A.; ZOUROB, Mohammed. Techniques for the detection of sickle cell disease: a review. Micromachines, v. 12, n. 5, p. 519, 2021.

ARLINGTON SCIENTIFIC. ASI Sickle Cell Test. 2024. Disponível em: https://www.arlingtonscientific.com/sickle-cell. Acesso em: 14 maio 2024.

BIOMEDOMICS. Point-of-Care and Laboratory Testing Products. 2024. Disponível em: https://www.biomedomics.com/products/. Acesso em: 18 mar. 2024.

BRASIL. Ministério da Saúde. Governo Federal lança Estratégia Nacional para o Desenvolvimento do Complexo Econômico-Industrial da Saúde com investimento de R$ 42 bilhões até 2026. 2023. Disponível em: https://www.gov.br/saude/ptbr/assuntos/noticias/2023/setembro/governo-federal-lanca-estrategia-nacional-para-odesenvolvimento-do-complexo-economico-industrial-da-saude-com-investimento-de-r-42- bilhoes-ate-2026. Acesso em: 24 jul. 2024.

BRASIL. Ministério da Saúde. Governo Federal reforça necessidade do diagnóstico precoce da Doença Falciforme. 2022. Disponível em: https://www.gov.br/saude/ptbr/assuntos/noticias/2022/junho/governo-federal-reforca-necessidade-do-diagnostico-precoceda-doenca-falciforme. Acesso em: 25 jul. 2024.

CDC – CENTERS FOR DISEASE CONTROL AND PREVENTION. Data & Statistics on Sickle Cell Disease. 2024. Disponível em: https://www.cdc.gov/ncbddd/sicklecell/data.html. Acesso em: 17 mar. 2024.

CDSCO – CENTRAL DRUGS STANDARD CONTROL ORGANIZATION. About Us CDSCO. 2024. Disponível em: https://cdsco.gov.in/opencms/opencms/en/about-us/Introduction/. Acesso em: 14 maio 2024.

CSIR – COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. About CSIR. 2024. Disponível em: https://www.csir.res.in/about-us/about-csir. Acesso em: 4 maio 2024.

DE ALMEIDA, Renata Araujo; BERETTA, A. L. R. Z. Anemia Falciforme e abordagem laboratorial: uma breve revisão de literatura. Revista Brasileira de Análises Clínicas, v. 49, n. 2, p. 131-134, 2017. Disponível em: https://www.rbac.org.br/wp-content/uploads/2017/08/RBAC-vol-49-2-2017-ref.-530-finalizado.pdf. Acesso em: 11 abr. 2024.

DERWENT INNOVATIONS. [Base de dados – Internet] (Clarivate Analytics). 2024. Disponível em: https://www.derwentinnovation.com//. Acesso em: 12 mar. 2024.

DEXTER, Daniel; MCGANN, Patrick T. Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease. British Journal of Haematology, v. 196, n. 1, p. 63-69, 2021. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/bjh.17678. Acesso em: 30 out. 2024.

DWPI – DERWENT WORLD PATENTS INDEX. Derwent World Patents Index (Clarivate Analytics). 2024. Disponível em: https://clarivate.com/products/ip-intelligence/ip-data-and-apis/derwent-world-patents-index/. Acesso em: 15 mar. 2024.

ENCORE BIOMEDICALS. Ensure Sickle cell Test. 2024. Disponível em: https://www.encorebiomedicals.com/assets/img/product/files/1709967210_product_files_48_1709967210154_6.pdf. Acesso em: 14 maio 2024.

FUKUOKA, Dyeila Hiriyumi et al. Anemia Falciforme. In: XII JORNACITEC-JORNADA CIENTÍFICA E TECNOLÓGICA. 2023. Anais [...]. [S.l.], 2023. Disponível em: http://www.jornacitec.fatecbt.edu.br/index.php/XIIJTC/XIIJTC/paper/viewFile/2983/3256. Acesso em: 11 abr. 2024.

IHME – INSTITUTE FOR HEALTH METRICS AND EVALUATION. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021. 2024. Disponível em: https://www.healthdata.org/research-analysis/library/global-regional-and-national-prevalence-and-mortality-burden-sickle-cell. Acesso em: 17 mar. 2024.

KANTER, Julie et al. Validation of a novel point of care testing device for sickle cell disease. BMC medicine, v. 13, p. 1-8, 2015.

KUMAR, Manoj; GUO, Yanyan; ZHANG, Peng. Highly sensitive and selective oligonucleotide sensor for sickle cell disease gene using photon upconverting nanoparticles. Biosensors and Bioelectronics, v. 24, n. 5, p. 1.522-1.526, 2009.

LANDIM, Andre Borges et al. Equipamentos e tecnologias para saúde: oportunidades para uma inserção competitiva da indústria brasileira. BNDES Setorial, n. 37, p. 173-226, março de 2013.

MACHADO, Laura de Souza Botelho et al. Aspectos bioquímicos e hematológicos da anemia falciforme. Revista Científica da Faculdade de Medicina de Campos, v. 16, n. 2, p. 79-88, 2021.

MEDOMICS. Sickle Cell Disease Rapid Test Kit (GICA). 2024. Disponível em: https://www.medomics-dx.net/product/Sickle-Cell-Disease-Rapid-Test-Kit-(GICA)-536.html. Acesso em: 14 maio 2024.

MORDOR INTELLIGENCE. Indústria de IVD – na Índia Análise de tamanho e participação – Tendências e previsões de crescimento (2024-2029). 2023. Disponível em: https://www.mordorintelligence.com/pt/industry-reports/india-in-vitro-diagnostics-market. Acesso em: 4 maio 2024.

MVUNDURA, Mercy et al. Cost for sickle cell disease screening using isoelectric focusing with dried blood spot samples and estimation of price thresholds for a point-of-care test in Uganda. Journal of Blood Medicine, p. 59-67, 2019. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC6368125/. Acesso em: 28 out. 2024.

NAGALAND POST. Mylab’s indigenous rapid test to detect Sickle Cell Anaemia in minutes. 2023. Disponível em: https://nagalandpost.com/index.php/2023/06/14/mylabs-indigenous-rapid-test-to-detect-sickle-cell-anaemia-in-minutes/. Acesso em: 14 mai. 2024. Acesso em: 29 out. 2024.

OLANIYAN, Halimat S. et al. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests. Blood Advances, v. 7, n. 19, p. 5.860-5.867, 2023. Disponível em: https://ashpublications.org/bloodadvances/article/7/19/5860/496691/Early-diagnosis-of-sickle-cell-disease-at-birth. Acesso em: 28 out. 2024.

OVTT – OBSERVATÓRIO VIRTUAL DE TRANSFERÊNCIA DE TECNOLOGIA. Organismos Internacionais de Propriedade Intelectual. 2024. Disponível em: https://www.ovtt.org/pt/recursos/organismos-internacionais-de-propriedade-intelectual/. Acesso em: 04 mai. 2024.

QUINN, Charles T. et al. A rapid, inexpensive and disposable point‐of‐care blood test for sickle cell disease using novel, highly specific monoclonal antibodies. British Journal of Haematology, v. 175, n. 4, p. 724-732, 2016.

REPORTS AND DATA. Global Sickle Cell Anemia Testing and Screening Market Size to Reach USD 503.04 Million in 2032. 2023. Disponível em: https://www.reportsanddata.com/press-release/global-sickle-cell-anemia-testing-and-screening-market. Acesso em: 17 mar. 2024.

SA SCIENTIFIC. SAS™ Rapid Diagnostic Test. 2024. Disponível em: https://www.sascientific.com/sas-rapid-diagnostic-tests/item/sickle-cell. Acesso em: 14 maio 2024.

STRECK. Product SICKLEDEX®. 2024. Disponível em: https://www.streck.com/products/sickle-cell/sickledex/#resources. Acesso em: 14 maio 2024.

THE INDIAN PRACTITIONER. CDSCO Approves Five Labs for Sickle Cell Disease IVD Testing. 2024. Disponível em: https://theindianpractitioner.com/cdsco-approves-five-labs-for-sickle-cell-disease-ivd-testing/. Acesso em: 14 maio 2024.

YANG, Xiaoxi et al. A simple, rapid, low-cost diagnostic test for sickle cell disease. Lab on a Chip, v. 13, n. 8, p. 1.464-1.467, 2013.

Downloads

Published

2025-10-01

How to Cite

Silva, M. M. R. da ., & Cabral, B. P. (2025). Technological Mapping of Point-of-Care Testing for the Diagnosis of Sickle Cell Anemia. Cadernos De Prospecção, 18(4), 1079–1088. https://doi.org/10.9771/cp.v18i4.61431

Issue

Vol. 18 No. 4 (2025)

Section

Prospecções Tecnológicas de Assuntos Específicos

License

Copyright (c) 2024 Cadernos de Prospecção

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

O autor declara que: - Todos os autores foram nomeados. - Está submetendo o manuscrito com o consentimento dos outros autores. - Caso o trabalho submetido tiver sido contratado por algum empregador, tem o consentimento do referido empregador. - Os autores estão cientes de que é condição de publicação que os manuscritos submetidos a esta revista não tenham sido publicados anteriormente e não sejam submetidos ou publicados simultaneamente em outro periódico sem prévia autorização do Conselho Editorial. - Os autores concordam que o seu artigo ou parte dele possa ser distribuído e/ou reproduzido por qualquer forma, incluindo traduções, desde que sejam citados de modo completo esta revista e os autores do manuscrito. - Revista Cadernos de Prospecção está licenciado com uma Licença Creative Commons Attribution 4.0. Esta licença permite que outros remixem, adaptem e criem a partir do seu trabalho para fins não comerciais, e embora os novos trabalhos tenham de lhe atribuir o devido crédito e não possam ser usados para fins comerciais, os usuários não têm de licenciar esses trabalhos derivados sob os mesmos termos. Licença Creative Commons
Este obra está licenciado com uma Licença Creative Commons Atribuição 4.0 Internacional.